Medicines for Europe has urged the CJEU to reject limits on the SPC manufacturing waiver involving export storage, third-country marketing authorizations and foreign patent rights.
Medicines for Europe has urged the CJEU to reject limits on the SPC manufacturing waiver involving export storage, third-country marketing authorizations and foreign patent rights.